King Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 672.7 | 465.6 | 519.5 |
| Net Investing Cash Flow | (776.3) | (436.3) | (683.0) |
| Net Financing Cash Flow | 9.8 | 54.5 | 0.9 |
| Net Change in Cash | (93.8) | 83.8 | (162.6) |
| Depreciation & Amortization | 175.9 | 150.4 | 150.1 |
| Capital Expenditures | (49.6) | (45.8) | (53.3) |
| Cash Dividends Paid | -- | -- | -- |





